Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
N-terminal pro B-type natriuretic peptide (NT-proBNP), a cardiac disease biomarker, has been demonstrated to be a strong independent predictor of cardiovascular events in patients without heart failure. Patients with peripheral arterial disease (PAD) are at high risk of cardiovascular events and dea...
Guardado en:
Autores principales: | Bader Alsuwailem, Abdelrahman Zamzam, Muzammil H Syed, Elisa Greco, Mark Wheatcroft, Charles de Mestral, Mohammed Al-Omran, John Harlock, John Eikelboom, Krishna K Singh, Rawand Abdin, Mohammad Qadura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd0e1b5e729e469d90ecb0222c5f7428 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Abdelrahman Zamzam, et al.
Publicado: (2021) -
NT-ProBNP levels in saliva and its clinical relevance to heart failure.
por: Jared Yong Yang Foo, et al.
Publicado: (2012) -
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
por: Lidia Staszewsky, et al.
Publicado: (2021) -
Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
por: Volker H. Schmitt, et al.
Publicado: (2021) -
The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease
por: Sheng Wang, et al.
Publicado: (2021)